Advances in AI — April 2024

In an 18-study meta-analysis involving over 4,600 patients, researchers found that bpMRI and mpMRI had equivalent pooled negative predictive value (NPV) of 92 percent for clinically significant prostate cancer (csPCa).

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Ultra-high spatial resolution with photon-counting CT facilitated a 33 percent reduction in the assessment of median total plaque volume and a 45 percent higher inter-reader agreement for evaluation of low-attenuation plaque volume in contrast to energy-integrating detector (EID) CT.

In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.

The F.A.S.T. aiCockpit CT Lung Nodule reportedly facilitates enhanced CT workflow and automated reporting for evaluation of lung nodules

A deep learning-enhanced ultra-fast bpMRI protocol offered similar sensitivity for csPCa as mpMRI with an 80 percent reduction in scan time, according to research findings presented at the European Congress of Radiology (ECR) conference.